中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
27期
188-189
,共2页
噻托溴铵%沙美特罗替卡松气雾剂%中重度COPD
噻託溴銨%沙美特囉替卡鬆氣霧劑%中重度COPD
새탁추안%사미특라체잡송기무제%중중도COPD
Tiotropium%Seretide%Severe COPD
目的:观察噻托溴铵联合沙美特罗替卡松气雾剂对中重度慢性阻塞性肺疾病(COPD)的临床疗效。方法从医院收治的中重度COPD患者中选取72例,均分为两组,对照组36例用沙美特罗替卡松气雾剂治疗,观察组36例用噻托溴铵联合沙美特罗替卡松气雾剂治疗,对比不同方法疗效。结果治疗后观察组肺功能指标改善情况、MMRC、6MWT评分改善优于对照组,P<0.05。结论噻托溴铵联合沙美特罗替卡松气雾剂治疗中重度COPD效果显著,优于沙美特罗替卡松气雾剂单药效果。
目的:觀察噻託溴銨聯閤沙美特囉替卡鬆氣霧劑對中重度慢性阻塞性肺疾病(COPD)的臨床療效。方法從醫院收治的中重度COPD患者中選取72例,均分為兩組,對照組36例用沙美特囉替卡鬆氣霧劑治療,觀察組36例用噻託溴銨聯閤沙美特囉替卡鬆氣霧劑治療,對比不同方法療效。結果治療後觀察組肺功能指標改善情況、MMRC、6MWT評分改善優于對照組,P<0.05。結論噻託溴銨聯閤沙美特囉替卡鬆氣霧劑治療中重度COPD效果顯著,優于沙美特囉替卡鬆氣霧劑單藥效果。
목적:관찰새탁추안연합사미특라체잡송기무제대중중도만성조새성폐질병(COPD)적림상료효。방법종의원수치적중중도COPD환자중선취72례,균분위량조,대조조36례용사미특라체잡송기무제치료,관찰조36례용새탁추안연합사미특라체잡송기무제치료,대비불동방법료효。결과치료후관찰조폐공능지표개선정황、MMRC、6MWT평분개선우우대조조,P<0.05。결론새탁추안연합사미특라체잡송기무제치료중중도COPD효과현저,우우사미특라체잡송기무제단약효과。
Objective To observe the effect of tiotropium combined with seretide for moderate to severe chronic obstructive pulmonary disease (COPD) clinical curative effect.Methods 72 cases from the hospital in severe COPD patients were randomly divided into two groups, the control group of 36 cases was treated with seretide in the treatment group of 36 cases with tiotropium bromide combined with seretide treatment, compared different methods curative effect observation.Results After treatment, the pulmonary function index of the observation group, 6MWT, MMRC score is better than the control group,P<0.05.Conclusion Tiotropium combined with seretide in the treatment of severe COPD signiifcant effect, better than seretide single drug.